newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

VERO BEACH, FL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company developing VT-7208, a Bruton's tyrosine kinase (BTK) inhibitor therapy for